Goldman Sachs’s PLx Pharma Inc. Common Stock PLXP Stock Holding History

Goldman Sachs’s Portfolio PLXP Stock Details PLXP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-12,620	Closed	-$2.07K	–	6379
2022 Q4	$2.07K	Buy	+12,620	New	+$5.28K	﹤0.01%	5876
2022 Q1	–	Sell	-31,802	Closed	-$255K	–	7068
2021 Q4	$255K	Buy	+31,802	New	+$373K	﹤0.01%	5756
2021 Q2	–	Sell	-13,658	Closed	-$123K	–	6652
2021 Q1	$123K	Buy	+13,658	New	+$99.8K	﹤0.01%	5783
2019 Q1	–	Sell	-19,671	Closed	-$30K	–	5539
2018 Q4	$30K	Sell	19,671 -14,263	-42%	-$50.9K	﹤0.01%	5129
2018 Q3	$137K	Buy	+33,934	New	+$128K	﹤0.01%	5035
2017 Q3	–	Sell	-11,450	Closed	-$70K	–	6934
2017 Q2	$70K	Buy	11,450 +8,403	+276%	+$61.5K	﹤0.01%	6267
2017 Q1	$32K	Hold	3,047	–	–	﹤0.01%	6403
2016 Q4	$39K	Sell	3,047 -4,432	-59%	-$163K	﹤0.01%	6456
2016 Q3	$868K	Sell	7,479 -2,303	-24%	-$225K	﹤0.01%	4547
2016 Q2	$776K	Sell	9,782 -4,173	-30%	-$362K	﹤0.01%	4427
2016 Q1	$1.06M	Buy	+13,955	New	+$887K	﹤0.01%	4028

Other funds holding PLXP

PWAM

Park West Asset Management San Francisco, California $1.18B AUM 47.25% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

GSC

Ground Swell Capital Folly Beach, South Carolina $50.7M AUM 30.19% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

UOTTAIMCU

University of Texas/Texas AM Investment Management Co (UTIMCO) Austin, Texas $687M AUM 21.33% 1-Year Est. Return

Synovus Financial Columbus, Georgia $8.74B AUM 12.78% 1-Year Est. Return

Goldman Sachs's PLXP Position: Q1 2023 in Review

Goldman Sachs sold out of PLx Pharma Inc. Common Stock (PLXP) in Q1 2023, closing a stake of 12,620 shares — an estimated $2.07K sold.

Goldman Sachs first reported a position in PLXP in Q1 2016 and held it in 11 quarters. The position peaked at $1.06M in Q1 2016. 34 funds tracked by Wall St. Rank hold PLXP as of Q1 2023.

Goldman Sachs reported no remaining PLx Pharma Inc. Common Stock position as of Q1 2023 after selling out during the quarter.
Goldman Sachs sold 12,620 PLx Pharma Inc. Common Stock shares in Q1 2023, an estimated $2.07K.
Goldman Sachs first reported a position in PLx Pharma Inc. Common Stock in Q1 2016 and held it in 11 quarters.
Goldman Sachs's PLx Pharma Inc. Common Stock position peaked at $1.06M in Q1 2016.
34 funds tracked by Wall St. Rank held PLx Pharma Inc. Common Stock as of Q1 2023.

Based on Goldman Sachs's 13F filing for Q1 2023, filed 11 May 2023.